BioSpace News Archive

Genetown

Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024 at 9:45am Pacific time.

December 7, 2023
·
1 min read
Business

Santhera Appoints Executive Committee Members as it Transitions into Commercial Stage

Pratteln, Switzerland, December 7, 2023 – Santhera Pharmaceuticals announces the promotion of Geert Jan van Daal, MD, PhD, to Chief Commercial Officer and of Marc Schrader to Chief Technology Officer.

December 7, 2023
·
4 min read
Policy

Ipsen confirms U.S. FDA grants priority review for New Drug Application for elafibranor for the treatment of rare cholestatic liver disease, PBC

Ipsen and GENFIT announced that the U.S. Food and Drug Administration has accepted the New Drug Application for investigational elafibranor.

December 7, 2023
·
14 min read
Policy

Sosei Group Announces Marketing Approval for PIVLAZ™ (clazosentan sodium) 150 mg in South Korea

Sosei Group Corporation announces that PIVLAZ™ 150 mg has received marketing approval from the Ministry of Food and Drug Safety in South Korea for the prevention of cerebral vasospasm, vasospasm-related cerebral infarction, and cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage securing.

December 7, 2023
·
8 min read
Drug Development

Faron Announces Publication of Full Analysis from Phase 1/2 MATINS Trial of Bexmarilimab in Solid Tumors in Cell Reports Medicine

Faron Pharmaceuticals Ltd. announces the publication of the full safety and anti-tumor efficacy results from the first-in-human Phase 1/2 MATINS trial of bexmarilimab in patients with treatment-refractory late-stage solid tumors in Cell Reports Medicine.

December 7, 2023
·
6 min read
AlzeCure Presents at Redeye Investor Forum in Göteborg on December 14

AlzeCure Pharma AB announced that the company is participating at Redeye Investor Forum in Göteborg on December 14 at 18:50 CET, where CEO Martin Jönsson will present and answer questions about the latest developments and the company’s plans going forward.

December 7, 2023
·
2 min read
Pharm Country

Regeneron to Share Progress of Novel Combination Therapies in Oncology at ESMO IO

Regeneron Pharmaceuticals, Inc. announced the presentation of new and updated data on multiple combination therapies from its oncology pipeline at the European Society for Medical Oncology Immuno-Oncology Congress 2023 from December 6 to 8 in Geneva, Switzerland.

December 7, 2023
·
19 min read
Drug Development

SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01

SpyBiotech announced that the first subject has been dosed with SPYVLP01, a candidate vaccine targeting human cytomegalovirus using its Hepatitis B virus-like-particle platform technology.

December 7, 2023
·
3 min read
Business

Rentschler Biopharma SE appoints Gunnar Voss von Dahlen as Chief Financial Officer and completes Executive Board

Rentschler Biopharma SE, a leading contract development and manufacturing organization for biopharmaceuticals, including Advanced Therapy Medicinal Products, announced that Gunnar Voss von Dahlen has been appointed as Chief Financial Officer, effective December 1, 2023.

December 7, 2023
·
4 min read
Bio NC

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024

United Therapeutics, a public benefit corporation, announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2024.

December 7, 2023
·
3 min read